COLPALNSEColgate Palmolive (India) Limited· Personal CareHighNeutral
Announced Fri, 22 May · 17:43 IST

Colgate Palmolive (India) Limited has informed the Exchange about change in Management

Management Changes View source PDF

COLPAL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-3.2%1-day move
₹2158.90
prior close
₹2185.70
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-1.7-1.0-1.5-4.5-3.2-3.1-4.4-7.7-7.6-7.1-2.8-7.8-1.1
Up moveDown movePending
AI summary

Colgate Palmolive (India) reported Q4 FY26 net sales of Rs. 1,583 crore, up 9% year-on-year, driven by broad-based portfolio performance. Q4 net profit was Rs. 353 crore. For the full year FY26, net sales stood at Rs. 5,984 crore (flat vs FY25), while net profit declined to Rs. 1,325 crore from Rs. 1,437 crore, impacted by inverted duty structure charges due to GST changes. The Board declared a second interim dividend of Rs. 24 per share, bringing total FY26 dividend to Rs. 48 per share (Rs. 653 crore payout). Additionally, the Board approved the re-appointment of Mr. Jacob Sebastian Madukkakuzy as Whole-time Director & CFO for another 5-year term starting October 28, 2026, subject to shareholder approval. Statutory auditors S R B C & Co LLP issued an unmodified audit opinion on the financial results.

Likely market impact

Positive for shareholders: strong Q4 sales rebound, continued dividend payouts, and CFO continuity signal management stability. The 9% quarterly sales growth and sustained premiumization strategy are encouraging, though full-year profit was impacted by regulatory changes.